Robin Weaver
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 5
- Oncology 3
- Viral-associated cancers and disorders 1
- HER2/EGFR in Cancer Research 1
- CAR-T cell therapy research 1
- Co-authors
- Antonio J Grillo-López (3 shared papers)Myron S. Czuczman (2 shared papers)Christine A. White (3 shared papers)Thomas A. Davis (2 shared papers)Ronald Levy (2 shared papers)Brian K. Link (2 shared papers)Baha Alkuzweny (2 shared papers)Peter McLaughlin (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Annual Review of Medicine (1 paper)Leukemia & lymphoma (1 paper)
- Partner nations
- United States
In The Last Decade
Robin Weaver
6 papers receiving 1.2k citations
Robin Weaver's Hit Papers
Peers
Comparison fields: 5 of 73
- Pathology and Forensic Medicine 750
- Genetics 395
- Oncology 467
- Radiology, Nuclear Medicine and Imaging 390
- Immunology 245
Countries citing papers authored by Robin Weaver
This map shows the geographic impact of Robin Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Weaver more than expected).
Fields of papers citing papers by Robin Weaver
This network shows the impact of papers produced by Robin Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Weaver. The network helps show where Robin Weaver may publish in the future.
Co-authors
The 21 scholars most cited alongside Robin Weaver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment Hit paper breakdown → | 2000 | 556 |
| 2 | 2004 | 290 | |
| 3 | 1999 | 243 | |
| 4 | 2001 | 112 | |
| 5 | 2006 | 24 | |
| 6 | Reducing Behavior Problems in the Elementary School Classroom. IES Practice Guide. NCEE 2008-012. | 2008 | 20 |
About Robin Weaver
Robin Weaver is a scholar working on Pathology and Forensic Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Genetics and Infectious Diseases, having authored 6 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Viral-associated cancers and disorders (1 paper), HER2/EGFR in Cancer Research (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (750 citations), Genetics (395 citations), Oncology (467 citations), Radiology, Nuclear Medicine and Imaging (390 citations) and Immunology (245 citations). Robin Weaver has collaborated with scholars based in United States. Frequent co-authors include Antonio J Grillo-López, Myron S. Czuczman, Christine A. White, Thomas A. Davis, Ronald Levy, Brian K. Link, Baha Alkuzweny, Peter McLaughlin, David G. Maloney and J. Rosenberg. Their work appears in journals such as Journal of Clinical Oncology, Annual Review of Medicine and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.